Meta Roestenberg is an infectious diseases clinician, professor in Human Models for Vaccine Development at Leiden University Medical Center in the Netherlands. She is head of the Leiden University Center for Infectious Diseases (LUCID), a large department with 400+ employees tasked with the clinical infectious diseases and medical microbiology care, teaching and research. Meta holds a medicine degree (cum laude), a PhD in medicine (cum laude) and is registered as a travel medicine and infectious diseases clinician and clinical pharmacist. She is also CEO of INFECTA, a not-for-profit CRO for early phase clinical trials in vaccines and medicine for infectious diseases with global impact. INFECTA holds a broad portfolio of controlled human infection models for malaria, Clostridioides, rhinovirus, influenza, RSV, chikungunya, hookworm and schistosomiasis and has many more in development. With support from the national government and key academic players in the Netherlands, INFECTA ambitions to become an international hub for infectious diseases product translation into the clinic, facilitating the rapid development of much needed novel products for infections which threaten humanity.